Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 23, 2019
Charles River Laboratories announced a definitive agreement to acquire HemaCare for approximately $380 million in cash.
read more
Monday, December 23, 2019
Compounded drugs can serve an important role in meeting patients’ medical needs that cannot be met by an FDA-approved drug.
read more
Monday, December 23, 2019
Lannett has received approvals from the FDA of its ANDAs for Butalbital, Acetaminophen and Caffeine Capsules.
read more
Monday, December 30, 2019
Sensyne Health has signed a research project with Roche.
read more
Monday, December 30, 2019
NPXe Limited has filed a voluntary petition to reorganize under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.
read more
Monday, December 30, 2019
Gilead Sciences and Eisai announced the two companies have entered into an agreement for the distribution and co-promotion of filgotinib, pending regulatory approval for rheumatoid arthritis.
read more
Monday, December 30, 2019
Mavidon is voluntarily recalling all lots of products manufactured at our facility including LemonPrep®, PediaPrep® and Wave Prep 4-ounce tubes and single use cups, Cardio Prep and Collodions, Collodion removers due to contamination with Burkholderia...
read more
Monday, December 30, 2019
Dr. Reddy’s announced the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial, the therapeutic generic equivalent of Nitropress® Injection.
read more
Monday, December 30, 2019
Acceleron and Fulcrum have entered into a collaboration and license agreement to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space.
read more
Monday, December 30, 2019
PharmaLink announced that it started Phase 1 of its expansion project in response to new contracts and increased demand for its reverse distribution services.
read more
Monday, December 30, 2019
Cyclo Therapeutics has signed a Master Services Agreement with Worldwide Clinical Trials to serve as CRO for the Company’s clinical programs evaluating Trappsol Cyclo.
read more
Monday, December 30, 2019
Verily is partnering with Emory Healthcare to deploy new solutions to help improve cost-effectiveness, operational efficiency and quality.
read more
Monday, December 30, 2019
GenScript has announced it signed a strategic collaboration agreement with Selecxine, a Korean biotech company dedicated to novel therapeutics for immuno-oncology.
read more
Monday, December 30, 2019
Sosei Group has been notified by its strategic alliance partner Pfizer that it has nominated a third clinical candidate from the multi-target drug discovery collaboration between the two companies.
read more
Monday, December 30, 2019
Check-Cap announced positive results from the Company's pilot study of the C-Scan® System in the U.S.
read more